Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. (Q39668614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

main subject

hepatocellular carcinoma

1 reference

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

James S Park

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

W Ray Kim

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Joseph Ahn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Joseph K Lim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Hannah M Lee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Anna S Lok

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mindie Nguyen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Calvin Q Pan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Helen Te

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Huy Trinh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Danny Chu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Tram Tran

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Daryl Lau

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Truong-Sinh Leduc

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Albert Min

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Loc Trong Le

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ho Bae

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sang Van Tran

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Son Do

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Hie-Won L Hann

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Clifford Wong

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Steven Han

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Anjana Pillai

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Myron Tong

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Steve Scaglione

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Jocelyn Woog

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

K Rajender Reddy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

language of work or name

English

0 references

publication date

21 June 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

1297-1304

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Hepatitis B virus-related cirrhosis: natural history and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Lamivudine for patients with chronic hepatitis B and advanced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.257

Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27325221

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/AJG.2016.257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27325221%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference